Mucosilent Gegen Reizhusten (Levodropropizine)

Levodropropizine, the active ingredient in Mucosilent Gegen Reizhusten, is an antitussive presented as an oral formulation for oral use. It suppresses irritative and dry cough by acting on sensory nerve fibers in the respiratory tract, and is indicated for adults and children with non‑productive cough. GNH USA supplies Mucosilent Gegen Reizhusten as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodropropizine is used to manage coughs that arise from irritation of the respiratory mucosa. - Irritative cough: reduces the frequency and intensity of cough triggered by throat or airway irritation. - Dry cough: provides relief from non‑productive cough without producing mucus. - Cough associated with upper respiratory infections: helps control coughing while the infection resolves.

Levodropropizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient light‑headedness. - Headache: occasional mild headache. - Dry mouth: reduced salivation. - Gastro‑intestinal discomfort: mild abdominal pain.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling. - Hepatic dysfunction: elevated liver enzymes. - Severe dizziness or vertigo. - Persistent vomiting. - Anaphylaxis: rare but potentially life‑threatening hypersensitivity.

Before using Levodropropizine, consider the following precautions. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss potential risks with a physician. - Liver impairment: use with caution; monitor hepatic function. - Renal impairment: dose adjustment may be required. - Concomitant CNS depressants: monitor for additive sedation. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levodropropizine may interact with other medicines; review the following categories.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Strong CYP450 inhibitors: may increase levodropropizine plasma levels.

Moderate Interactions (Monitor Closely): - Antihistamines: possible additive sedation. - Other antitussives: risk of excessive cough suppression. - Alcohol: may enhance dizziness or drowsiness.